Market Overview

Netflix Unveils Details Around Chelsea Handler's Debut

Netflix Unveils Details Around Chelsea Handler's Debut

Netflix, Inc. (NASDAQ: NFLX)'s foray into the talk show format will officially begin May 11.

Chelsea Handler, who has come on board to host the currently unnamed new series, made the announcement on Wednesday via Twitter. It was a fitting way to break the news given Handler's consistent presence across social media.

In the note, Handler explained her new talker will air three a days week on Netflix (Wednesday-Friday) and will run for 30 minutes with no commercial breaks. More information is expected to be revealed in the coming days, but for now this is the main information coveted by investors.

Related Link: Here's Some Concerning Data About Primetime TV

Handler made headlines when she left her former home E! to come to Netflix, but at the time that was all that was revealed. Talk shows are one area not currently on the streaming giant and an area its executive team has previously said was of great interest.

What investors will want to know next is the show's exact format, which based on Handler's note make it seem she may not be confined to a traditional studio and desk. Given Netflix's disruptor status, that's not a real surprise but since the network has never done daily episodic content, when shareholders get answers, it seems to prompt more questions.

Image credit: David Shankbone, Flick

Posted-In: Chelsea HandlerNews Events Tech Media Best of Benzinga


Related Articles (NFLX)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Goldman Sachs Considers Implications For Regeneron, Amgen, Sanofi Following PCSK9 Ruling

CBS Maps Out Sweeps Strategy As Numerous Shows Get Extra Airings